Jesper Foged Havelund (Jesper F Havelund, Jesper Havelund)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Insulin Resistance

Advanced Non Small Cell Lung Cancer

Top Venues

The Journal of clinical endocrinology and metabolism

EMBO molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Johan D Onslev, Matteo Fiorenza, Martin Thomassen, Jesper Foged Havelund, Jens Bangsbo, Nils Færgeman, Jørgen F P Wojtaszewski, Morten Hostrup
Beta2-agonist impairs muscle insulin sensitivity in persons with insulin resistance. The Journal of clinical endocrinology and metabolism (2024)
Vignesh Ramesh, Paradesi Naidu Gollavilli, Luisa Pinna, Mohammad Aarif Siddiqui, Adriana Martinez Turtos, Francesca Napoli, Yasmin Antonelli, Aldo Leal-Egaña, Jesper Foged Havelund, Simon Toftholm Jakobsen, Elisa Le Boiteux, Marco Volante, Nils Joakim Færgeman, Ole Nørregaard Jensen, Rasmus Siersbaek, Kumar Somyajit, Paolo Ceppi
Propionate reinforces epithelial identity and reduces aggressiveness of lung carcinoma. EMBO molecular medicine (2023)
Sebastian Møller Nguyen Heimbürger, Bjørn Hoe, Chris Neumann Nielsen, Natasha Chidekel Bergmann, Kirsa Skov-Jeppesen, Bolette Hartmann, Jens Juul Holst, Flemming Dela, Julie Overgaard, Joachim Størling, Tina Vilsbøll, Thomas Fremming Dejgaard, Jesper Foged Havelund, Vladimir A Gorshkov, Frank Kjeldsen, Nils Joakim Færgeman, Martin Rønn Madsen, Mikkel Bring Christensen, Filip K Krag Knop
GIP Affects Hepatic Fat and Brown Adipose Tissue Thermogenesis but Not White Adipose Tissue Transcriptome in Type 1 Diabetes. The Journal of clinical endocrinology and metabolism 107 (12) (2022)
Kathrine B Dall, Jesper Foged Havelund, Eva B Harvald, Michael Witting, Nils Joakim Færgeman
HLH-30-dependent rewiring of metabolism during starvation in C. elegans. Aging cell 20 (4) (2021)